Mawer Investment Management Ltd. Sells 345,921 Shares of Organon & Co. (NYSE:OGN)

Mawer Investment Management Ltd. lowered its position in Organon & Co. (NYSE:OGN – Free Report) by 2.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 12,847,934 shares of the company’s stock after selling 345,921 shares during the quarter. Organon & Co. […]

Related Keywords

Wellington ,New Zealand General ,New Zealand ,United States ,America ,Nexplanon Implanon ,Piper Sandler ,Exchange Commission ,Goldman Sachs Group ,Wellington Shields Capital Management ,Massmutual Trust Co ,Glassman Wealth Services ,Quarter For Organon Co ,Mawer Investment Management Ltd ,Morgan Stanley ,Capital Management Inc ,Penserra Capital Management ,Company Profile ,Organon Co ,News Ratings For Organon Co ,Mawer Investment Management ,Free Report ,Investment Management ,Shields Capital Management ,Capital Management ,Wealth Services ,Massmutual Trust ,Get Free Report ,Ganirelix Acetate Injection ,Visit Holdingschannel ,Nyse Ogn ,Ogn ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,